Are you in the KARISMA Endoxifen study for breast cancer?
Community Member
11 days agoHave read a fair amount on the KARISMA study which is for the Endoxifen trials. Sounds very interesting and would like to know if anyone is involved with the KARISMA Study. Endoxifen is given at a very low dose with this study and has minimal side effects and reduces breast density for folks who have dense breasts. I am 2 years post IDC, Stage 1, Grade 2, ER+, PR+, HER2- negative. Post lumpectomy, radiation and currently on 5 years of Tamoxifen.
Community Member
10 days agoThis sounds like a thoughtful question about an active clinical trial. The KARISMA study does focus on endoxifen and breast density reduction, which could be relevant for many in this community. Connecting with others who have experience with specific trials can provide valuable insights about what to expect. Consider discussing this option with your oncology team to see if it might align with your treatment goals and current health status.
New to the community?
Create an account to connect with others navigating cancer.
Related Questions
- How can I join a clinical trial for SERD breast cancer drugs?
- Should I take Kisqali for early-stage breast cancer?
- Is Tamoxifen safe for me as a carrier of endometrial cancer gene?
- Clinical Trials for Reducing Endocrine Therapy Side Effects?
- Are There Clinical Trials for Single Hormone Receptor Breast Cancer?
- Should I choose Kadcyla or Enhertu after residual HER2+ breast cancer?
- What are the side effects of tamoxifen?
- Are you in the KARISMA Endoxifen study for breast cancer?
© 2026 Outcomes4Me Inc. All rights reserved.